Market Domination host Josh Lipton takes a look at some of Friday's trending tickers and stories. Merck (MRK) announced it will cut staff from one of its HPV vaccine factories. Jefferies (JEF) stock ...

Tempus AI Inc. TEM on Tuesday inked a strategic collaboration agreement with Merck & Co. Inc. MRK aimed at accelerating AI-driven precision medicine. The stock’s decline comes as broader markets ...

Tempus AI, Inc. (NASDAQ:TEM) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026. On March 3, the company ...

A giant in the healthcare space, Merck (NYSE:MRK) shares are up 13.5% year-to-date and trading near $119.47, yet retail sentiment on Reddit has slipped from a bullish 63 over the past quarter to a ...

Merck isn't exciting in the same way as GLP-1 leader Eli Lilly. But it presents an opportunity for investors who use ...

Shares of Merck & Co. Inc. MRK slipped 1.30% to $119.83 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.94% to 6,816.63 ...

If you are wondering whether Merck's share price still offers value after a strong run, you are not alone. This article is built to help you frame that question clearly. At a last close of US$123.93, ...

Merck has increased its dividend for 14 consecutive years. Its 10-year dividend growth rate of 5.4% is only decent. Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY ...

The drugmaker is splitting up its Human Health business before patent protection on its blockbuster treatment Keytruda expires in two years.

In the latest close session, Merck (MRK) was down 1.95% at $121.41. This move lagged the S&P 500's daily gain of 0.04%. Meanwhile, the Dow experienced a drop of 0.15%, and the technology-dominated ...

Merck & Co. shares clocked seven straight sessions of gains, as the stock was up 0.2% at $124.1 on Tuesday. The global healthcare company gained 2% in the preceding six sessions.